Waleed al Muhairi

Waleed Al Muhairi currently serves as a Member of the Board of Directors at M42 Health and holds the position of Deputy Group CEO at Mubadala since January 2021. With extensive board involvement, Waleed is also a Board Member at Ellipses Pharma, First Abu Dhabi Bank, ALDAR Properties PJSC, Investcorp, Hub71, and has been appointed Chairman of both Waha Capital and the Global Institute for Disease Elimination (GLIDE). Waleed has served on the Board of Trustees at Cleveland Clinic since 2012. Educational qualifications include a Master’s degree in Public Policy from Harvard University and a Bachelor’s degree in Science in Foreign Service from Georgetown University.